압타머사이언스

291650KOSDAQ자연과학 및 공학 연구개발업

57.8 / 100

Reference Date: 2026-07-24

Financial Score22.0 / 40

News Sentiment13.8 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 26.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

AptaMera Science is a biotech company spun off from POSTECH in 2011, specializing in the development of innovative therapeutics based on aptamer technology and offering CRO services for biopharmaceutical analysis. Utilizing its proprietary ApDC® platform, the company is advancing the development of targeted anti-cancer drugs for solid and hematologic malignancies, with key candidates like AST-201 and AST-202 in clinical trials, and expanded into CRO services in 2024.

Number of Employees

44people

Average Salary

54.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

2.05Industry Average 2.524.0Point

In line with industry avg

ROE

-32.13Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

3.91Industry Average 7.315.0Point

Lower than industry avg (good)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲284.5% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲15.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -45.2% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 1Average Sentiment Score 55

Negative
거래소 "압타머사이언스, 22일부터 주권매매거래정지"
압타머사이언스의 주권매매거래 정지로 인해 투자자들의 불안감이 증가하고 있다.
Neutral
압타머사이언스, '츌립앤사이언스'로 사명 변경
압타머사이언스의 사명 변경은 경영 전략 변화를 반영하지만, 직접적인 재무 영향은 제한적이다.

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 950Won52-week high 1,94152-week low 684

1-month return6.0Point

1m +26.33% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-07-16
Neutral임시주주총회결과2026-07-08
Neutral상호변경안내2026-07-08